I can’t give exact construction or setup costs for a propofol manufacturing plant. Building and running a compliant, licensed facility for a regulated IV anesthetic involves strict cGMP requirements, safety/regulatory hurdles, and security controls, and costs vary wildly by capacity, location, and whether you’re making API only or also doing sterile fill/finish and finished dosage forms.
That said, here are the main cost drivers and what they typically imply at a high level:
Key cost drivers
- Capacity and scope
- API production only vs. API plus sterile fill/finish for finished products (emulsion IV formulations).
- Target annual production volume (kg/year for API; number of vials or liters for finished product) and batch sizes.
- Facility and cleanrooms
- Dedicated GMP manufacturing space with appropriate cleanrooms (often ISO 5/ISO 7 for sterile areas).
- HVAC, containment, explosion/flare risk considerations, utilities, fire protection, and safety systems.
- Equipment
- Reactors, purification/filtration systems, solvent handling and recovery, safety systems.
- For the IV/emulsion product: sterile filtration, aseptic fill-finish line, filling/packaging equipment, and in-process testing.
- Regulatory and quality systems
- Process development and tech transfer, validation (IQ/OQ/PQ), quality control labs, stability studies.
- Documentation, audits, regulatory filings, and ongoing compliance activities.
- Utilities and waste management
- Solvent waste treatment, water purification, energy and utilities, and hazardous waste handling.
- Security and governance
- Access controls, asset security, and regulatory oversight for a drug product (even if propofol isn’t a scheduled substance everywhere, manufacturing is tightly regulated).
- Raw materials and supply chain
- Sourcing of active pharmaceutical ingredient precursors and excipients; reliability and price volatility of solvents and emulsifiers.
- Permitting and site services
- Local permits, environmental impact assessments, utility connections, and insurance.
Rough, non-specific budget guidance (very generalized)
- Pilot or small-scale API-only setup: tens of millions of USD (ballpark; highly variable by region and what’s included).
- Full commercial facility including API production plus sterile fill/finish for finished propofol emulsion dosage forms: potentially in the tens to hundreds of millions of USD.
- Large, fully integrated operations with state-of-the-art containment, robust QA/QC labs, and extensive validation could exceed hundreds of millions.
How to get a more precise estimate
- Define your target capacity and product scope (API only vs. finished dosage form; expected batch sizes; number of packaging lines).
- Engage with engineering firms and CDMOs early for feasibility studies and high-level CAPEX estimates.
- Talk to equipment vendors (for both API synthesis/ purification and sterile fill/finish lines) to get ballpark quotes based on your design and region.
- Consult regulatory experts to understand the approvals, validation, and documentation burden for your intended markets.
- Consider location factors (labor costs, utility costs, permitting timeline, and import/export regulations) which can dramatically affect total cost.
If you want, I can help you sketch a rough, non-binding framework for an feasibility study (capacity, regulatory path, and major cost buckets) or compare API-only vs. API plus sterile fill/finish scenarios at a high level. Do you have details on target capacity, region, and whether you need finished dosage form production as well as API?